Effects of endotoxin derived from Escherichia coli lipopolysaccharide on the pharmacokinetics of drugs

Archives of Pharmacal Research

Volumn 31, Issue 9, 2008, Pages 1073-1086

  Yang, Kyung Hee ^a   Lee, Myung Gull ^a  

^a Seoul National University   (South Korea)

Author keywords

ECLPS; Hepatic and intestinal CYP isozymes; Pharmacokinetics; Rat; Urinary excretion

Indexed keywords

ENDOTOXIN; ENDOTOXIN, ESCHERICHIA COLI; LIPOPOLYSACCHARIDE;

ANIMAL; DRUG EFFECT; HUMAN; KIDNEY; LIVER; METABOLISM; PHARMACOKINETICS; REVIEW;

ANIMALS; ENDOTOXINS; HUMANS; KIDNEY; LIPOPOLYSACCHARIDES; LIVER; PHARMACOKINETICS;

EID: 52649161281     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-001-1272-8     Document Type: Review

References (82)

1. C. Y. Ahn E. J. Kim I. Lee J. W. Kwon W. B. Kim S. G. Kim M. G. Lee 2003 Effects of glucose on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate J. Pharm. Sci. 92 1604 1613
2. H. W. Baek S. K. Bae M. G. Lee Y. T. Sohn 2006 Pharmacokinetics of chlorozoxazone in rats with diabetes: induction of CYP2E1 on 6-hydroxychlorzoxazone formation J. Pharm. Sci. 95 2454 2462
3. M. G. Bergeron Y. Bergeron 1986 Influence of endotoxin on the intrarenal distribution of gentamicin, netilmicin, tobramycin, amikacin, and cepharlothin Antimicrob. Agents Chemother. 29 7 12
4. R. Bertini M. Bianchi A. Erroi P. Villa P. Ghezzi 1989 Dexamethasone modulation of in vivo effects of endotoxin, tumor necrosis factor, and interleukin-1 on liver cytochrome P-450, plasma fibrinogen, and serum iron J. Leukoc. Biol. 46 254 262
5. C. Botas F. Poulain J. Akiyama C. Brown L. Allen J. Goerke J. Clements E. Carlson A. M. Gillespie C. Epstein S. Hawgood 1998 Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D Proc. Natl. Acad. Sci. USA. 95 11869 11874
6. C. Carbon C. Contrepois A. M. Vigneron A. Lamotte-Barrillon 1980 Effects of furosemide on extravascular diffusion, protein binding and urinary excretion of cephalosporins and aminoglycosides in rabbits J. Pharmacol. Exp. Ther. 213 600 606
7. M. A. Cassatella L. Meda S. Bonora M. Ceska G. Constantin 1993 Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide J. Exp. Med. 78 2207 2211
8. D. Cavanagh P. S. Rao D. M. Sutton B. D. Bhagat F. Bachmann 1970 Pathophysiology of endotoxin shock in the primate Am. J. Obstet. Gynecol. 108 705 722
9. L. Chen C. S. Yang 1996 Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats Life Sci. 58 1575 1585
10. P.-Y. Cheng M. Wang E. T. Morgan 2003 Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin J. Pharmacol. Exp. Ther. 307 1205 1212
11. H. J. Chung M. G. Lee 2008 Effect of water deprivation for 72 hours on the pharmacokinetics of ipriflavone in rats Res. Vet. Sci. 85 149 155
12. W.-S. Chung E. J. Kim I. Lee S. G. Kim M. G. Lee S. H. Kim 2003 Effects of recombinant human growth hormone on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate Life Sci. 73 253 263
13. H. J. Chung Y. H. Choi S. H. Kim M. G. Lee 2006 Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous ipriflavone in rats J. Pharm. Pharmacol. 58 449 457
14. Chung, H. J., Kang, H. E., Bae, E. J., Lee, I., Kim, S. G., and Lee, M. G., Effects of E. coli lipopolysaccharide on the pharmacokinetics of ipriflavone and its metabolites, M1 and M5, after intravenous and oral administration of ipriflavone to rats: decreased metabolism of ipriflavone due to decreased expression of hepatic CYP1A2 and 2C11. J. Pharm. Sci., (in press) (2008).
15. P. C. Churchill A. K. Bidani M. M. Schwartz 1987 Renal effects of endotoxin in the male rat Am. J. Physiol. 253 F244 F250
16. A. H. Conney J. J. Burns 1960 Physiological disposition and metabolic fate of chlorzoxazone (Paraflex) in man J. Pharmacol. Exp. Ther. 128 340 343
17. E. K. Crawford J. E. Ensor I. Kalvakolanu J. D. Hasday 1997 The role of 3′ poly(A) tail metabolism in tumor necrosis factor-alpha regulation J. Biol. Chem. 272 21120 21127
18. E. C. Crouch 1998 Collectins and pulmonary host defense Am. J. Respir. Cell. Mol. Biol. 19 177 201
19. G. Engel U. Hofmann H. Heidemann J. Cosme M. Eichelbaum 1996 Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethyl-antipyrine, and norantipyrine formation Clin. Pharmacol. Ther. 59 613 623
20. T. J. Evans E. Strivens A. Carpenter J. Cohen 1993 Differences in cytokine response and induction of nitric oxide synthase in endotoxin-resistant and endotoxin-sensitive mice after intravenous gram-negative infection J. Immunol. 150 5033 5040
21. M. A. Freudenberg D. Keppler C. Galanos 1986 Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin Infect. Immun. 51 891 895
22. R. P. Gilbert 1960 Mechanisms of the hemodynamic effects of endotoxin Physiol. Rev. 40 245 279
23. F. Gorodischer J. Krasner J. J. McDevitt J. P. Nolan S. J. Yaffe 1976 Hepatic microsomal drug metabolism after administration of endotoxin in rats Biochem. Pharmacol. 25 351 353
24. H. Halkin M. Lidji E. Rubinstein 1981 The influence of endotoxin-induced pyrexia on the pharmacokinetics of gentamicin in the rabbit J. Pharmacol. Exp. Ther. 216 415 418
25. J. F. Herbein J. R. Wright 2001 Enhanced clearance of surfactant protein D during LPS-induced acute inflammation in rat lung Am. J. Physiol. Lung. Cell Mol. Physiol. 281 268 277
26. J. A. Hewett R. A. Roth 1993 Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides Pharmacol. Rev. 45 382 411
27. L. B. Hinshaw G. M. Brandley C. H. Carlson 1959 Effect of endotoxin on renal function in the dog Am. J. Physiol. 196 1127 1131
28. A. D. Jernigan R. C. Hatch R. C. Wilson J. Brown S. M. Tuler 1988 Pharmacokinetics of gentamicin in cats given Escherichia coli endotoxin Am. J. Vet. Res. 49 603 607
29. J. Kalitsky-Szirtes A. Shayeganpour D. R. Brocks M. Piquette-Miller 2004 Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats Drug Metab. Dispos. 32 20 27
30. D. Kikeri J. P. Pennell K. H. Hwang A. I. Jacob A. V. Richman J. J. Bourgoignie 1986 Endotoxemic acute renal failure in awake rats Am. J. Physiol. 250 F1098 F1106
31. S. H. Kim M. G. Lee 2002 Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects Life Sci. 70 1299 1315
32. Y. G. Kim M. K. Cho J. W. Kwon S. G. Kim S. J. Chung C.-K. Shim M. G. Lee 2002 Effects of cysteine on the pharmacokinetics of intravenous chlorzoxazone in rats with protein-calorie malnutrition Biopharm. Drug Dispos. 23 121 129
33. Y. C. Kim I. Lee S. G. Kim S. H. Ko M. G. Lee S. H. Kim 2006 Effects of glucose supplementation on the pharmacokinetics of intravenous chlorzoxazone in rats with water deprivation for 72 h Life Sci. 79 2179 2186
34. G. O. Kokwaro S. Ismail A. P. Glazier S. A. Ward G. Edwards 1993 Effect of malaria infection and endotoxin-induced fever on the metabolism of antipyrine and metronidazole in the rat Biochem. Pharmacol. 45 1243 1249
35. G. O. Kokwaro A. P. Glazier S. A. Ward A. M. Brechenridge G. Edwards 1993 Effect of malaria infection and endotoxin-induced fever on phenacetin O-deethylation by rat liver microsomes Biochem. Pharmacol. 45 1235 1241
36. T. R. Korfhagen V. Sheftelyevich M. S. Burhans M. D. Bruno G. F. Ross S. E. Wert M. T. Stahlmann A. H. Jobe M. Ikegami J. A. Whitsett J. H. Fisher 1998 Surfactant protein D regulates surfactant phospholipid homeostasis in vivo J. Biol. Chem. 273 28438 28443
37. I. Kushner 1982 The phenomenon of the acute phase response Ann. N. Y. Acad. Sci. 389 39 48
38. V. Leclercq J. P. Desager Y. Horsmans Y. van Nieuwenhuyze C. Harvengt 1989 Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine Int. J. Clin. Pharmacol. Ther. Toxicol. 27 593 598
39. J. H. Lee M. G. Lee 2007 Effects of acute renal failure on the pharmacokinetics of telithromycin in rats: negligible effects of increase in CYP3A1 on the metabolism of telithromycin Biopharm. Drug Dispos. 28 157 166
40. J. H. Lee M. G. Lee 2007 Dose-dependent pharmacokinetics of telithromycin after intravenous and oral administration to rats: contribution of intestinal first-pass effect to low bioavailability J. Pharm. Pharm. Sci. 10 37 50
41. J. H. Lee Y. K. Cho Y. S. Jung Y. C. Kim M. G. Lee 2008 Effects of E. coli lipopolysaccharide on telithromycin pharmacokinetics in rats: inhibition of metabolism via CYP3A Antimicrob. Agents Chemother. 52 1046 1051
42. Levy, R. H., Thummel, K. E., Trager, W. F., Hansten, P. D., and Eichelbaum, M., Metabolic Drug Interactions. Philadelphia, BA, USA: Lippincott Williams & Wilkins, a Wolters Kluwer Company (2000).
43. Lewis, D. F. V., Chapter 4. P450. Substrate specificity and metabolism. In Cytochromes P450, Structure, Function and Mechanism. Lewis DFV (ed) 2nd edn. Bristol, PA, USA: Taylor & Francis, 1996; 123.
44. P. Liu G. M. McGuire M. A. Fisher A. Farhood C. W. Smith H. Jaeschke 1995 Activation of Kupffer cells and neutrophils for reactive oxygen formation is responsible for endotoxin-enhanced liver injury after hepatic ischemia Shock 3 56 62
45. M. Llewelyn J. Cohen 2001 New insights into the pathogenesis and therapy of sepsis and septic shock Curr. Clin. Top. Infect. Dis. 21 148 171
46. S. Loft H.E. Poulsen 1989 Metabolism of metronidazole and antipyrine in isolated rat hepatocytes. Influence of sex and enzyme induction and inhibition Biochem. Pharmacol. 38 1125 1126
47. D. Mailman 2002 Ileal luminal nitric oxide synthase inhibitors and E. coli lipopolysaccharide effects in the anesthetized rat Dig. Dis. Sci. 47 190 200
48. M. Monshouwer R. A. McLellan E. Delaporte R. F. Witkamp A. S. van Miert K. W. Renton 1996 Differential effect of pentoxifylline on lipopolysaccharide- induced downregulation of cytochrome P450 Biochem. Pharmacol. 52 1195 1200
49. Y. J. Moon A. K. Lee H. C. Chung E. J. Kim S. H. Kim D. C. Lee I. Lee S. G. Kim M. G. Lee 2003 Effects of acute renal failure on the pharmacokinetics of chlorzoxazone in rats Drug Metab. Dispos. 31 776 784
50. E. T. Morgan 1989 Suppression of constitutive cytochrome P-450 gene expression in livers of rats undergoing an acute phase response to endotoxin Mol. Pharmacol. 36 699 707
51. E. T. Morgan 1993 Down-regulation of multiple cytochrome P450 gene products by inflammatory mediators in vivo. Independence from the hypothalamo-pituitary axis Biochem. Pharmacol. 45 415 419
52. M. Nadai T. Sekido I. Matsuda W. Li K. Kitaichi A. Itoh T. Nabeshima T. Hasegawa 1998 Time-dependent effects of Klebsiella pneumoniae endotoxin on hepatic drug-metabolizing enzyme activity in rats J. Pharm. Pharmacol. 50 871 879
53. M. Ngeleka P. Auclarim D. Tardif D. Beauchamp M. Bergeron 1989 Intrarenal distribution of vancomycin in endotoxemic rats Antimicrob. Agents Chemother. 33 1575 1579
54. C. Nilsson J. Aschan P. Hentschke O. Ringden P. Ljungman M. Hassan 2003 The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation Bone Marrow Transplant. 31 429 435
55. Y. Ohkawa M. Matsumura Y. Kurosaki M. Kurumi K. Sasaki T. Nakayama 2001 Effects of 4-hydroxyantipyrine and its 4-O-sulfate on antipyrine as biodistribution promoter Biol. Pharm. Bull. 24 529 534
56. Ortiz de Montellano, P. R., Cytochrome P450. Structure, Mechanism, and Biochemistry. 3rd edn. New York, USA: Kluwer Academic/Plenum Publishers (2005).
57. E. Pastoriza-Munoz R. L. Bowman G. J. Kaloyanides 1979 Renal tubular transport of gentamicin in the rat Kidney Int. 16 440 450
58. S. M. Poloyac R. T. Tosheva B. M. Gardner S. I. Shedlofsky R. A. Blouin 1999 The effect of endotoxin administration on the pharmacokinetics of chlorzoxazone in humans Clin. Pharmacol. Ther. 66 554 562
59. K. Rajanarayana M. S. Reddy D. R. Krishna 2003 Diosmin pretreatment affects bioavailability of metronidazole Eur. J. Clin. Pharmacol. 58 803 807
60. D. Remick P. Manohar G. Bolgos J. Rodriguez L. Moldawer G. Wollenberg 1995 Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture Shock 4 89 95
61. E. T. Rietschel T. Kirikae F. U. Schade A. J. Ulmer O. Holst H. Brade G. Schmidt U. Mamat H. D. Grimmecke S. Kusumoto 1993 The chemical structure of bacterial endotoxin in relation to bioactivity Immunobiology 187 169 190
62. K. Rockich R. Blouin 1999 Effect of the acute-phase response on the pharmacokinetics of chlorzoxazone and cytochrome P-450 2E1 in vitro activity in rats Drug Metab. Dispos. 27 1074 1077
63. A. L. Roe G. Warren G. Hou G. Howard S. I. Shedlofsky R. A. Blouin 1998 The effect of high dose endotoxin on CYP3A2 expression in the rat Pharm. Res. 15 1603 1608
64. K. Sachdeva B. Yan C. O. Chichester 2003 Lipopolysaccharide and cecal ligation/puncture differentially affect the subcellular distribution of the pregnane X receptor but consistently cause suppression of its target genes CYP3A Shock 19 469 474
65. D. Sesardic A. R. Boobis J. R. Edwards D. S. Davies 1988 A form of cytocrome P-450 in man orthologous to form in the rat catalyses the O-deetylation of phenacetin and is inducible by cigarette smoking Br. J. Clin. Pharmacol. 26 363 372
66. M. B. Sewer E. T. Morgan 1998 Down-regulation of the expression of three major rat liver cytochrome P450S by endotoxin in vivo occurs independently of nitric oxide production J. Pharmacol. Exp. Ther. 287 352 358
67. M. B. Sewer D. R. Koop E. T. Morgan 1996 Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450 Drug Metab. Dispos. 24 401 407
68. J. Shi G. Montay V. O. Bhargava 2005 Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial Clin. Pharmacokinet. 44 915 934
69. F. J. Silverblatt C. Kuehn 1979 Autoradiography of gentamicin uptake by the rat proximal tubule cell Kidney Int. 15 335 345
70. T. Szakacs Z. Veres L. Vereczkey 2001 Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes Pol. J. Pharmacol. 53 11 19
71. M. O. M. Tanira B. H. Ali A. K. Bashir 1997 Effect of endotoxin on gentamicin pharmacokinetics in old and young adult rats Life Sci. 60 413 424
72. D. Tarif D. Beauchamp M. G. Bergeron 1990 Influence of endotoxin on the intracortical accumulation kinetics of gentamicin in rats Antimicrob. Agents Chemother. 34 576 580
73. J. Ueyama M. Nadai H. Kanazawa M. Iwase H. Nakayama K. Hashimoto T. Yokoi K. Baba K. Takagi K. Takagi T. Hasegawa 2005 Endotoxin from various gram-negative bacteria has differential effects on function of hepatic cytochrome P450 and drug transporters Eur. J. Pharmacol. 510 127 134
74. O. Westphal K. Jann K. Himmelspach 1983 Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins Prog. Allergy 33 9 39
75. G. R. Wilkinson D. G. Shand 1975 A physiological approach to hepatic drug clearance Clin. Pharmacol. Ther. 18 377 390
76. R. C. Wilson J. N. Moore N. Eakle 1983 Gentamicin pharmacokinetics in horses given small doses of Escherichia coli endotoxin Am. J. Vet. Res. 44 1746 1749
77. R. C. Wilson D. D. Goetsch T. L. Huber 1984 Influence of endotoxin-induced fever on the pharmacokinetics of gentamicin in ewes Am. J. Vet. Res. 45 2495 2497
78. J. R. Wright 1997 Immunomodulatory functions of surfactant Physiol. Rev. 77 931 962
79. K. Wright E. T. Morgan 1990 Transcriptional and post-transcriptional suppression of P450IIC11 and P450IIC12 by inflammation FEBS Lett. 271 59 61
80. W. Yamreudeewong M. DeBisschop L. G. Martin D. L. Lower 2003 Potentially significantly drug interactions of class III antiarrhythic drugs Drug Saf. 26 421 438
81. K. H. Yang M. G. Lee 2007 Effects of lipopolysaccharide endotoxin on pharmacokinetics of drugs J. Toxicol. Pub. Health 23 289 299
82. K. H. Yang Y. S. Jung D. Y. Lee J. H. Lee Y. C. Kim M. G. Lee 2008 Time-dependent effects of Klebsiella pneumoniae endotoxin (KPLPS) on the pharmacokinetics of theophylline in rats; return of the parameters in 96-h KPLPS rats to the control levels Drug Metab. Dispos. 36 811 815